Mutations in MAATP53, EGFR, FAT4, KMT2C, ARID1A, FAT1, and RNF213 were observed in the original cancer tissues, whereas KRAS and BRAF mutations were not identified (Figure 4C). This evidence concerns the gene KMT2C and cancer.